Sparsh Bio Tech

We take immense pleasure in introducing Sparsh Bio-Tech Private Limited . An Exclusive WHO-GMP certified Dedicated β-Lactum facility, manufacturing finished formulation in Tablets, Capsules & Dry Syrup form since more than a decade. Sparsh is considered among TOP 5 β-Lactum manufacturing facilities in India with monthly installed capacity of 150 Million Capsules , 50 Million Tablet & 2 Million Dry Syrups per month. Sparsh is a 100 % Export Oriented Unit located in the city of Jamnagar situated in state of Gujarat – INDIA. Sparsh has its facility and products registered in more than 40 countries across the globe with main geographies in continent of Africa , Asia and Latin America. With manufacturing finished formulations of 2nd and 3rd generation penicillin such as Amoxicillin , Ampicillin , Cloxacillin , Pen V, we have added 4th generation penicillin such as Flucloxacillin , Dicloxacillin , Oxacillin Sulbactam and combination product such as Amoxicillin with Clavulanate Potassium. Sparsh has a dedicated AmoxiClav manufacturing unit servicing its clients with multiple dosage forms such as Tablet, Dry Syrups and Sachets. Sparsh Strength’s and Key Highlights 1. Safe and Efficacious Product 2. Cost Effective Product 3. Timely Delivery 4. Quick Response Time